Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 168.61M P/E 32.82 EPS this Y -42.20% Ern Qtrly Grth -
Income 21.59M Forward P/E 18.05 EPS next Y -34.60% 50D Avg Chg 6.00%
Sales 235.64M PEG 0.09 EPS past 5Y - 200D Avg Chg 3.00%
Dividend N/A Price/Book 6.52 EPS next 5Y 232.50% 52W High Chg -30.00%
Recommedations 3.00 Quick Ratio 1.45 Shares Outstanding 48.21M 52W Low Chg 74.00%
Insider Own 15.12% ROA 9.19% Shares Float 29.40M Beta 1.31
Inst Own 66.91% ROE 57.54% Shares Shorted/Prior 3.29M/4.09M Price 3.61
Gross Margin 73.40% Profit Margin 9.16% Avg. Volume 216,567 Target Price 4.33
Oper. Margin 21.37% Earnings Date May 2 Volume 122,028 Change 1.69%
About Puma Biotechnology Inc

Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company offers NERLYNX, an oral version of neratinib that is used to treat adult patients with early stage HER2-overexpressed/amplified breast cancer; and advanced or metastatic HER2-positive breast cancer when combined with capecitabine. It also develops alisertib, a small molecule inhibitor of aurora kinase A for the treatment of hormone receptor positive breast cancer, triple negative breast cancer, small cell lung cancer, and head and neck cancer. The company sells its products through specialty pharmacy and distributor networks. It has license agreements with Pfizer Inc. for the development, manufacture, and commercialization of neratinib (oral), neratinib (intravenous), PB357, and related compounds; and Takeda Pharmaceutical Company Limited for the research, development, and commercialization of alisertib, as well as sub-license agreements with Specialised Therapeutics Asia Pte Ltd., Medison Pharma Ltd., Pint Pharma International SA, Knight Therapeutics, Inc., Pierre Fabre Medicament SAS, and Bixink Therapeutics Co., Ltd. The company was founded in 2010 and is headquartered in Los Angeles, California.

Puma Biotechnology Inc News
04/08/24 Puma Biotechnology (NASDAQ:PBYI) shareholders have earned a 93% return over the last year
04/03/24 Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
03/22/24 Puma Biotechnology (PBYI) Soars 14.0%: Is Further Upside Left in the Stock?
03/22/24 Do Puma Biotechnology's (NASDAQ:PBYI) Earnings Warrant Your Attention?
03/20/24 Puma Biotechnology Announces FDA Allowance to Proceed Under IND for Alisertib in HER2-Negative, Hormone Receptor-Positive Metastatic Breast Cancer
03/05/24 FDA Lifts Clinical Hold on Iovance's (IOVA) Lung Cancer Study
03/04/24 J&J (JNJ) Secures Full FDA Nod for Rybrevant in Lung Cancer
03/02/24 Puma Biotechnology, Inc. (NASDAQ:PBYI) Q4 2023 Earnings Call Transcript
03/02/24 Puma Biotechnology, Inc. (NASDAQ:PBYI) Shares Could Be 47% Below Their Intrinsic Value Estimate
03/01/24 Q4 2023 Puma Biotechnology Inc Earnings Call
03/01/24 Why Puma Biotech (PBYI) is a Top Value Stock for the Long-Term
03/01/24 Puma Biotechnology (PBYI) Q4 Earnings & Revenues Lag Estimates
03/01/24 Amarin's (AMRN) Q4 Earnings and Revenues Surpass Estimates
02/29/24 Puma Biotechnology Inc (PBYI) Reports Positive Net Income for Q4 and Full Year 2023
02/29/24 Puma Biotechnology Reports Fourth Quarter and Full Year 2023 Financial Results
02/29/24 Sarepta (SRPT) Q4 Earnings Beat Estimates, Revenues Up Y/Y
02/29/24 Mirum's (MIRM) Q4 Earnings Lag Estimates, Revenues Beat
02/27/24 Rocket (RCKT) Registers Narrower-Than-Expected Loss in Q4
02/27/24 Puma Biotechnology (PBYI) to Report Q4 Earnings: What's in Store?
02/22/24 Puma Biotechnology to Participate in a Panel Discussion at TD Cowen’s 44th Annual Health Care Conference
PBYI Chatroom

User Image bbtb Posted - 2 hours ago

$PBYI this company is done if u own lot of shares ure done be warned

User Image bbtb Posted - 3 hours ago

$PBYI these people total asswipes

User Image Gius_me Posted - 5 hours ago

$PBYI laughing and joking…we are closed to the trial

User Image Rob997 Posted - 11 hours ago

$PBYI Hey @bbtb what else bad can happen to this company ? ))))

User Image bbtb Posted - 1 day ago

$PBYI this company is done. Legal expenses will hit them hard.a

User Image bbtb Posted - 1 day ago

$PBYI they won't get a dime from wyeth

User Image bbtb Posted - 1 day ago

$PBYI this dump belongs at 2.

User Image bbtb Posted - 1 day ago

$PBYI this company is garbage what a forecast more sales warnings

User Image bbtb Posted - 2 days ago

$PBYI this company done when earnings come out it will be back to 3 they will give sales warning

User Image Rob997 Posted - 2 days ago

$PBYI https://casetext.com/case/puma-biotechnology-inc-v-astrazeneca-pharm-1

User Image bbtb Posted - 3 days ago

$PBYI what asswioes luwuig Alan maximo

User Image bbtb Posted - 4 days ago

$PBYI what asswipes mngmnt Maximo Ludwig stupid ceo

User Image bbtb Posted - 5 days ago

$PBYI geez what a company lousy forecast countersuit claims no growth only in phase 2 how it went to 6.

User Image Jonnyking Posted - 1 week ago

$PBYI she went back to 6 today, 7 next.

User Image PSDL75 Posted - 1 week ago

$PBYI @Jonnyking you sell my man?

User Image bbtb Posted - 1 week ago

$PBYI wait for earnings

User Image PSDL75 Posted - 1 week ago

$PBYI good AACR conference for them?

User Image biovalidator Posted - 1 week ago

$PBYI should see AACR conference abstract data today, cheers to Friday

User Image PMD777 Posted - 2 weeks ago

$PBYI crickets here- everyone sell?

User Image Stock_Titan Posted - 2 weeks ago

$PBYI Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) https://www.stocktitan.net/news/PBYI/puma-biotechnology-reports-inducement-awards-under-nasdaq-listing-359nbldk7x9k.html

User Image commoncentsinvestor Posted - 2 weeks ago

$PBYI Anyone looking for a stock that could have a big increase in share price in 2024 might want to take a look at CVRX. They got FDA approval for its Barostim product to improve the lives of people suffering from heart failure back in 2019. They have spent the last 4 years building a market for their product and it is about to reap big rewards. They have been increasing their revenues, the number of implant centers, their territories, , and their public visibility by leaps and bounds and work on 84% gross margins. This should all result in big increases in revenues and share price this year. I expect a minimum of $65M in 2024 revenues and with 84% Gross Margins, a 15 times Market Cap would be very reasonable. That would put the share price at about $47. Current Share Price is under $18. With only 600 followers on Stock Twits, it is very early in the game for folks who like to invest in under followed small companies with HUGE potential.

User Image StockInvest_us Posted - 2 weeks ago

Signal alert: $PBYI - PivotPoint bottom https://stockinvest.us/l/vLkspOhAMi

User Image bbtb Posted - 03/31/24

$PBYI how can counterclaim defendant be positive they are screwed

User Image bbtb Posted - 03/30/24

$PBYI what junk management

User Image bbtb Posted - 03/30/24

$PBYI this company total junk really garbage

User Image bbtb Posted - 03/30/24

$PBYI garbage ceo should be axed legal expenses at least 10million

User Image bbtb Posted - 03/29/24

$PBYI this company total junk next 2 years 65m debt due plus legal expenses next quarter losses they only do phase 2 trials they need to do secondary soon. Dilution 20 million shares. What a garbage company. They have should have never been on the lawsuit. Let Wyeth do it alone.

User Image bbtb Posted - 03/28/24

$PBYI this company is total junk thr ceo cfo and commerce idiots

User Image learningafterfailing Posted - 03/28/24

$PBYI Short go down 1M shares already, but we still stuck at $5 only. so sad ... seem like no future, seem like we are going to be dead stock here. So sad for my mistake 😢

User Image PSDL75 Posted - 03/27/24

$PBYI been noticing some top side resistance?

Analyst Ratings
HC Wainwright & Co. Buy Mar 1, 24
HC Wainwright & Co. Buy Feb 13, 24
HC Wainwright & Co. Buy Sep 20, 23
HC Wainwright & Co. Buy Aug 4, 23
HC Wainwright & Co. Buy Jun 5, 23
HC Wainwright & Co. Buy May 5, 23
HC Wainwright & Co. Buy Mar 6, 23
HC Wainwright & Co. Buy Aug 5, 22
HC Wainwright & Co. Buy May 6, 22
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Wong Alvin F Chief Scientific Off.. Chief Scientific Officer Dec 04 Sell 3.7608 280 1,053 97,934 01/10/24
Wong Alvin F Chief Scientific Off.. Chief Scientific Officer Jan 03 Sell 4.4859 7,733 34,689 98,214 01/05/24
Ludwig Jeffrey Jerome Chief Commercial Off.. Chief Commercial Officer Jan 03 Sell 4.4859 12,956 58,119 99,970 01/05/24
AUERBACH ALAN H President and CEO President and CEO Jan 03 Sell 4.4859 41,396 185,698 6,936,947 01/05/24
NOUGUES MAXIMO F Chief Financial Offi.. Chief Financial Officer Jan 03 Sell 4.4859 15,682 70,348 128,666 01/05/24
HUNT DOUGLAS M See Remarks See Remarks Jan 03 Sell 4.4859 8,358 37,493 103,319 01/05/24
Wong Alvin F Chief Scientific Off.. Chief Scientific Officer Jul 03 Sell 3.3112 6,938 22,973 105,947 07/06/23
NOUGUES MAXIMO F Chief Financial Offi.. Chief Financial Officer Jul 03 Sell 3.3112 14,680 48,608 144,348 07/06/23
Ludwig Jeffrey Jerome Chief Commercial Off.. Chief Commercial Officer Jul 03 Sell 3.3112 12,103 40,075 112,926 07/06/23
HUNT DOUGLAS M See Remarks See Remarks Jul 03 Sell 3.3112 7,809 25,857 111,677 07/06/23
AUERBACH ALAN H President and CEO President and CEO Jul 03 Sell 3.3112 60,698 200,983 6,978,343 07/06/23
WILSON TROY EDWARD Director Director Jun 13 Sell 3.45 27,000 93,150 350 06/15/23
MOYES JAY M Director Director Jun 13 Sell 3.45 22,000 75,900 16,322 06/15/23
Stuglik Brian M Director Director Jun 13 Sell 3.46 9,900 34,254 31,958 06/15/23
Senderowicz Adrian Director Director Jun 13 Sell 3.45 27,000 93,150 06/15/23
Dorval Allison Director Director Jun 13 Sell 3.45 10,000 34,500 17,000 06/15/23
MILLER MICHAEL PATRICK Director Director Jun 13 Sell 3.45 13,500 46,575 41,358 06/15/23
AUERBACH ALAN H President and CEO President and CEO Jan 03 Sell 4.1779 27,241 113,810 6,852,638 01/05/23
AUERBACH ALAN H President and CEO President and CEO Dec 02 Sell 4.49780 1,251 5,627 6,311,698 12/06/22
HUNT DOUGLAS M See Remarks See Remarks Dec 02 Sell 4.49780 429 1,930 75,575 12/06/22
NOUGUES MAXIMO F Chief Financial Offi.. Chief Financial Officer Dec 02 Sell 4.49780 159 715 110,926 12/06/22
Wong Alvin F Chief Scientific Off.. Chief Scientific Officer Dec 02 Sell 4.49780 514 2,312 58,013 12/06/22
HUNT DOUGLAS M See Remarks See Remarks Nov 02 Sell 2.25 429 965 76,004 11/04/22
AUERBACH ALAN H President and CEO President and CEO Nov 02 Sell 2.25 1,242 2,794 6,312,949 11/04/22
NOUGUES MAXIMO F Chief Financial Offi.. Chief Financial Officer Nov 02 Sell 2.25 163 367 111,085 11/04/22
NOUGUES MAXIMO F Chief Financial Offi.. Chief Financial Officer Oct 03 Sell 2.3354 165 385 111,248 10/05/22
HUNT DOUGLAS M See Remarks See Remarks Oct 03 Sell 2.3354 435 1,016 76,433 10/05/22
AUERBACH ALAN H President and CEO President and CEO Oct 03 Sell 2.3354 1,260 2,943 6,314,191 10/05/22
MILLER MICHAEL PATRICK Director Director Aug 09 Sell 3.5517 25,000 88,792 54,858 08/10/22
NOUGUES MAXIMO F Chief Financial Offi.. Chief Financial Officer Aug 02 Sell 2.89 161 465 111,577 08/04/22
NOUGUES MAXIMO F Chief Financial Offi.. Chief Financial Officer Jul 05 Sell 2.6315 9,328 24,547 111,738 08/04/22
HUNT DOUGLAS M See Remarks See Remarks Aug 02 Sell 2.89 429 1,240 77,301 08/04/22
AUERBACH ALAN H President and CEO President and CEO Aug 02 Sell 2.89 1,247 3,604 6,316,705 08/04/22
HUNT DOUGLAS M See Remarks See Remarks Jul 05 Sell 2.6315 3,753 9,876 77,730 07/07/22
AUERBACH ALAN H President and CEO President and CEO Jul 05 Sell 2.6315 26,140 68,787 6,317,952 07/07/22
Ludwig Jeffrey Jerome Chief Commercial Off.. Chief Commercial Officer Jul 05 Sell 2.6315 5,835 15,355 64,625 07/07/22
Wong Alvin F Chief Scientific Off.. Chief Scientific Officer Jul 05 Sell 2.6315 2,920 7,684 58,527 07/07/22
Senderowicz Adrian Director Director Jun 16 Sell 2.6313 27,858 73,303 27,000 06/21/22
WILSON TROY EDWARD Director Director Jun 16 Sell 2.5835 27,858 71,971 27,350 06/21/22
Stuglik Brian M Director Director Jun 16 Sell 2.686 13,000 34,918 41,858 06/21/22
MOYES JAY M Director Director Jun 16 Sell 2.6411 22,858 60,370 38,322 06/21/22
Wong Alvin F Chief Scientific Off.. Chief Scientific Officer Jun 02 Sell 1.9241 587 1,129 61,447 06/06/22
NOUGUES MAXIMO F Chief Financial Offi.. Chief Financial Officer Jun 02 Sell 1.9218 162 311 121,066 06/06/22
HUNT DOUGLAS M See Remarks See Remarks Jun 02 Sell 1.9441 417 811 81,483 06/06/22
AUERBACH ALAN H President and CEO President and CEO Jun 02 Sell 1.9441 1,200 2,333 6,344,092 06/06/22
HUNT DOUGLAS M See Remarks See Remarks May 03 Sell 2.3101 438 1,012 81,900 05/05/22
NOUGUES MAXIMO F Chief Financial Offi.. Chief Financial Officer May 03 Sell 2.3401 165 386 121,228 05/04/22
AUERBACH ALAN H President and CEO President and CEO May 03 Sell 2.3201 1,263 2,930 6,345,292 05/04/22
AUERBACH ALAN H President and CEO President and CEO Apr 04 Sell 3.078 1,198 3,687 6,346,555 04/05/22
NOUGUES MAXIMO F Chief Financial Offi.. Chief Financial Officer Apr 04 Sell 3.078 206 634 121,393 04/05/22